Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Monsanto and others look to RNA interference to fight widespread bee-killing mites.
Using RNA instead of DNA could avoid the health risks–and the political pitfalls–of stem-cell treatments.
Scientists have uncovered genetic targets that could increase lung-cancer cells’ sensitivity.
Monsanto is developing genetically modified plants that use RNA interference to kill the insects that eat them.
The decision should reduce uncertainty in the field of molecular diagnostics.
A new type of genetic switch gives bioengineers better control over microbes.
Nanotubes can transport RNA into the human immune system’s white blood cells, making the cells less vulnerable to attack by the HIV virus.
A unique class of RNA drugs could bring new treatments to cancer and other diseases.
A new study reveals the influence of large RNA molecules in controlling stem cells.
Drugmakers place big bets on the emerging science of microRNA.